ICUI
ICU MedicalCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-11
Current thesis
The post-earnings bull read is that May 7, 2026 results beat the limited checked consensus on both revenue and adjusted EPS, gross margin improved to 39% from 35%, and core Consumables plus Infusion Systems both grew year over year despite the IV Solutions divestiture [#8-K-2026-05-07] [#10-Q-2026-05-07].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +17.1.
What can break
Foreign exchange, tariffs, and single/limited-source supply exposure are still explicitly flagged by management as forward risks [#8-K-2026-05-07].
Momentum
70
Value
56
Sentiment
32
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $118.00 · Bull $145.00 · Bear $102.00
Data freshness
Prices
As of 2026-06-11
Fundamentals
As of 2026-06-10 • Vendor: Data Vendor v1
Scores
As of 2026-06-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-11
Investment thesis
As of 2026-06-11
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $183.60
Why
Momentum70 · Δ7d +17.1
Value56 · Δ7d -0.4
Sentiment32 · Δ7d -10.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
70
34% active weight
Current posture
7d trendImproving
Δ7d
+17.1
Δ21d
+44.6
Value
56
32% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.6
Sentiment
32
33% active weight
Current posture
7d trendSoftening
Δ7d
-10.3
Δ21d
-7.1
Why this grade
Composite grade C. Momentum 69.7 / Value 56.4 / Sentiment 32.1
Fundamentals (TTM)As of 2026-06-10
Fundamentals (TTM)
As of 2026-06-10
Market Cap
$3.49B
Beta
0.80
Shares Out
24.69M
P/E (TTM) · Derived
4766.6
P/S (TTM)
1.53
P/FCF (TTM)
57.17
Rev YoY
-8.9%
EPS YoY
+89.8%
Gross Margin
+36.5%
Op Margin
+5.2%
Net Debt
$1.28B
Current Ratio
2.45
As of 2026-06-11 • Updated nightlySource: Internal modelMethodology

